Can Ata

Can Ata

Auto-generated profile, based on publicly available information

Can Ata


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2024 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
CACan Ata
Can Ata
SESelcuk Erkılınc
Selcuk Erkılınc

10 June 2024 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
OYONUR YAVUZ
ONUR YAVUZ
HAHüseyin Aytuğ Avşar
Hüseyin Aytuğ Avşar
CACan Ata
Can Ata
SESelçuk Erkılınç
Selçuk Erkılınç
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
Vitamin D evaluation in adenomyosis: A retrospective cross-sectional study - Turkish Journal of Obstetrics and Gynecology

1 May 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
UAUfuk Atlihan
Ufuk Atlihan
OYOnur Yavuz
Onur Yavuz
CACan Ata
Can Ata
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
SESelcuk Erkilinc
Selcuk Erkilinc
Background: To evaluate the efficacy and long-term safety of treatment with dienogest in patients with endometrioma.Methods: Patients with endometrioma-related chronic pelvic pain were included in this retrospective study from March 2018 to March 2023. Enrolled patients received 2 mg of dienogest once daily. Data from 180 patients were analyzed. Group 2 (n = 104, 57.8%), comprising patients undergoing long-term therapy (>12 months), was compared with group 1 (n = 76, 42.2%), consisting of patients undergoing short-term therapy (<2 months), regarding their response to changes in endometrioma size and visual analog scale (VAS) scores. Statistical analysis was performed using the SPSS version 26.0 software. Non-normally distributed parameters were analyzed using the Mann–Whitney U test. In the evaluation of the data, apart from identifying statistical methods, the t-test was used in comparison of paired groups, and the matched t-test was used in the determination of changes before and after treatment. The Chi-square test and Fisher’s precision test were used in the analysis of categorical data. Categorical variables are presents as percentages, and quantitative variables are summarized as mean (95% confidence intervals) and median (minimum-maximum). p-values of 12 months) were compared one by one with the findings at T0. The reduced libido was 4.3 times higher in the long-term group, but the weight gain was higher in the short-term group. Analysis within all patients and individual groups (short term vs. long term) showed a significant decrease in endometrioma size and VAS scores between T0 and T1 visit findings. Similarly, the findings of T2 and each subsequent visit of the patients in the long-term group were compared with the initial findings and a significant reduction in endometrioma size and VAS scores was observed.Conclusion: Although the effectiveness of dienogest treatment for endometrioma seems to begin in the sixth month, its effectiveness maximizes in patients whose treatment duration is over 1 year.

19 May 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
UAUfuk Atlihan
Ufuk Atlihan
CACan Ata
Can Ata
OYOnur Yavuz
Onur Yavuz
HAHuseyin Aytug Avsar
Huseyin Aytug Avsar
SESelcuk Erkilinc
Selcuk Erkilinc
TBTevfik Berk Bildaci
Tevfik Berk Bildaci
Background: Platelet-rich plasma (PRP) is considered safe and is a low-cost, simple, natural, and minimally invasive method for vaginal rejuvenation. We aimed to compare the effects of hormonal treatment options and PRP use for postmenopausal vulvovaginal atrophy (VVA).Methods: From a total of 66 patients, topical estrogen treatment was administered to 36 patients, and PRP treatment was used on 30 patients who had previously received topical estrogen treatment without obtaining a response. To assess the impact of VVA and associated symptoms on the quality of life of patients, three different questionnaires, namely the Vaginal Health Index (VHI), Female Sexual Function Index (FSFI), and the Vulvovaginal Symptoms Questionnaire (VSQ), along with a Visual Analog Scale (VAS), were administered at 4-week intervals.Results: In the assessment at the 12th week, the FSFI and VSQ results obtained in patients treated with PRP showed a significant difference compared with those treated with topical estrogen (p = 0.004 and p < 0.001, respectively).Conclusion: PRP injections are a safe and effective minimally invasive monotherapy for postmenopausal VVA and, consequently, vulvovaginal rejuvenation. PRP injections are regarded as a promising method for the treatment of VVA in postmenopausal patients with contraindications to hormone therapy and improving hydration of the vaginal mucosa.

23 March 2025 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
OYONUR YAVUZ
ONUR YAVUZ
BEBurak Ersak
Burak Ersak
CACan Ata
Can Ata
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
USUlas Solmaz
Ulas Solmaz

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
Ufuk AtlıhanUfuk Atlıhan
Ufuk Atlıhan
TBTevfik Berk Bildacı
Tevfik Berk Bildacı
SESelçuk Erkılınç
Selçuk Erkılınç
OYONUR YAVUZ
ONUR YAVUZ
HAHüseyin Aytuğ Avşar
Hüseyin Aytuğ Avşar
CACan Ata
Can Ata
Aim: It is very important to uncover the relationship between Hydrosalpinx, which occurs as a result of chronic-inflammatory-processes, and inflammatory markers. Our study aimed to investigate the role of Neutrophil/Lymphocyte Ratio(NLR), Platelet/Lymphocyte Ratio(PLR), and Mean Platelet Volume(MPV) values in the diagnosis of patients who had Hydrosalpinx. Materials and Methods: Our study included 349 patients, who applied to our clinic between March 2018-June 2023, were diagnosed with primary or secondary infertility, and for this reason underwent Hysterosalpingography. A total of 89 patients who had Hydrosalpinx and 260 patients who did not have Hydrosalpinx were divided into 2 groups, and the demographic, clinical data were compared retrospectively. Results: Neutrophil and Platelet levels were found to be significantly higher in the Hydrosalpinx-group than the control group(p:0.000).The presence of Hydrosalpinx was found to be significantly higher in patients who were diagnosed with secondary infertility(p:0.000).Neutrophil and Platelet levels were significantly higher in the bilateral-Hydrosalpinx-group than the unilateral-Hydrosalpinx-group(p:0.036,p:0.012, respectively). The NLR and PLR were found to be significantly higher in the bilateral-Hydrosalpinx-group than the unilateral–Hydrosalpinx-group(p:0.038,p:0.009, respectively). MPV were found to be significantly lower in the bilateral-Hydrosalpinx-group than the unilateral-Hydrosalpinx-group(p:0.011). Conclusion: The findings of our study support the literature data on the relationship between NLR,PLR,MPV, and chronic inflammatory processes. These markers deserve to be evaluated again and again in prospective and controlled studies, in which they will be considered together with clinical findings, to investigate their ability to predict the diagnosis of Hydrosalpinx, its severity, and clinical outcomes in infertile patients.